Cargando…
Ultrasound combined with nanobubbles promotes systemic anticancer immunity and augments anti-PD1 efficacy
BACKGROUND: The poor immunogenicity of solid tumors limits the efficacy ofanti-programmed cell death protein 1 (anti-PD1)-based immune checkpoint blockade (ICB); thus, less than 30% of patients with cancer exhibit a response. Currently, there is still a lack of effective strategies for improving tum...
Autores principales: | Hu, Jianjun, He, Jiangyi, Wang, Yunlong, Zhao, Yang, Fang, Kejing, Dong, Yan, Chen, Yanrong, Zhang, Yue, Zhang, Chi, Wang, Hongwei, Tan, Jun, Wang, Junyi, Zi, Ruiyang, Liu, Chengxiang, Liang, Houjie, Guo, Yanli, Ou, Juanjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896049/ https://www.ncbi.nlm.nih.gov/pubmed/35236741 http://dx.doi.org/10.1136/jitc-2021-003408 |
Ejemplares similares
-
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy
por: Groeneveldt, Christianne, et al.
Publicado: (2022) -
Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy
por: Ravirala, Divya, et al.
Publicado: (2021) -
Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1
por: Hoang, Huy-Dung, et al.
Publicado: (2023) -
Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies
por: Roulstone, Victoria, et al.
Publicado: (2021) -
Recombinant Mycobacterium smegmatis delivering a fusion protein of human macrophage migration inhibitory factor (MIF) and IL-7 exerts an anticancer effect by inducing an immune response against MIF in a tumor-bearing mouse model
por: Jeong, Hyein, et al.
Publicado: (2021)